Pfizer

Nov
19
2021
0 Comments
By Troy Warren
Pfizer agrees to let other companies make its COVID-19 pill

Pfizer agrees to let other companies make its COVID-19 pill

COVID-19, In The News,
By MARIA CHENG, Associated Press Troy Warren for CNT #COVID-19 LONDON — Drugmaker Pfizer Inc. has signed a deal with a U.N.-backed group to allow other manufacturers to make its experimental COVID-19 pill, a move that could make the treatment available to more than half the world’s population. In a statement issued Tuesday, Pfizer said it would grant a license for the antiviral pill to the Geneva-based Medicines Patent Pool, which would let generic drug companies produce the pill for use in 95 countries, making up about 53% of the world’s population. The deal excludes some large countries that have suffered…
Read More
Nov
06
2021
0 Comments
By Troy Warren
New COVID-19 pill cut hospital, death risk by 90%

New COVID-19 pill cut hospital, death risk by 90%

COVID-19,
By MATTHEW PERRONE, Associated Press Troy Warren for CNT #COVID-19 WASHINGTON — Pfizer Inc. said Friday that its experimental antiviral pill for COVID-19 cut rates of hospitalization and death by nearly 90% as the drugmaker joins the race to bring the first easy-to-use medication against the coronavirus to the U.S. market. Currently all COVID-19 treatments used in the U.S. require an IV or injection. Competitor Merck’s COVID-19 pill is already under review at the Food and Drug Administration after showing strong initial results, and on Thursday the United Kingdom became the first country to OK it. Pfizer said it will ask…
Read More
Aug
23
2021
0 Comments
By Troy Warren
BREAKING: Pfizer COVID-19 vaccine gets full FDA approval

BREAKING: Pfizer COVID-19 vaccine gets full FDA approval

COVID-19, In The News, ,
By The Associated Press Troy Warren for CNT #COVID-19 WASHINGTON — The U.S. gave full approval to Pfizer’s COVID-19 vaccine on Monday, a milestone that may help lift public confidence in the shots as the nation battles the most contagious coronavirus mutant yet. The vaccine made by Pfizer and its partner BioNTech now carries the strongest endorsement from the Food and Drug Administration, which has never before had so much evidence to judge a shot’s safety. More than 200 million Pfizer doses already have been administered in the U.S. — and hundreds of millions more worldwide — since emergency use began…
Read More
Jul
12
2021
By Troy Warren
Pfizer to discuss COVID-19 vaccine booster with U.S. officials

Pfizer to discuss COVID-19 vaccine booster with U.S. officials

COVID-19,
By The Associated Press Troy Warren for CNT WASHINGTON — Pfizer says it plans to meet with top U.S. health officials Monday to discuss the drugmaker’s request for federal authorization of a third dose of its COVID-19 vaccine as President Joe Biden’s chief medical adviser acknowledged that “it is entirely conceivable, maybe likely” that booster shots will be needed. The company said it was scheduled to have the meeting with the Food and Drug Administration and other officials Monday, days after Pfizer asserted that booster shots would be needed within 12 months. Pfizer’s Dr. Mikael Dolsten told The Associated Press last…
Read More